RxDoctor Payments Data

Courtney George, MD

Internal Medicine · Knoxville, TNNPI 1730287764

Payments from drug & device makers

$2,317in general payments, 2019–2025

Across 129 payments — averaging $17.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$512
  • GSK$306
  • Novartis$236
  • AstraZeneca$235
  • Pfizer$183
  • Amgen$113
  • plus $732 from 23 others

What the payments were for

  • Food & beverage$2,317100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,317 in reported general payments places this provider in the 75th percentile of 2,216 internal medicine providers in Tennessee.

See all internal medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$85,982
Medicare patients
195
Services billed
867

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide45$59,911
JardianceEmpagliflozin56$55,727
MounjaroTirzepatide35$52,118
Repatha SureclickEvolocumab33$44,140
EliquisApixaban31$40,373
OzempicSemaglutide25$33,785
Repatha SyringeEvolocumab15$23,517
JanuviaSitagliptin Phosphate11$13,698
Trelegy ElliptaFluticasone/Umeclidin/Vilanter19$13,473
XareltoRivaroxaban13$11,685
LinzessLinaclotide13$6,560
Rosuvastatin Calcium269$3,002
Famotidine211$2,785
Levothyroxine Sodium302$2,331
Losartan Potassium252$2,182

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$31$112,02980 claims
Boehringer IngelheimJardiance$63$55,72756 claims
PfizerEliquis$183$40,37331 claims
Novo NordiskOzempic$512$33,78525 claims
GSKTrelegy Ellipta$306$13,47319 claims
AbbVieLinzess, Synthroid$90$8,47549 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,216 internal medicine providers in Tennessee.

Other internal medicine in Knoxville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →